Pediatric Vaccines Market is expected to reach US$ 34.06 billion by 2031, growing at a CAGR of 5.7% - Pfizer Inc., Sanofi SA, Merck & Co.

The Global Pediatric Vaccines Market reached US$ 22.09 billion in 2023 and is expected to reach US$ 34.06 billion by 2031, growing at a CAGR of 5.7% during the forecast period 2024-2031.

Pediatric Vaccines Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/pediatric-vaccines-market?rk

Pediatric vaccines are immunizations designed to protect children from infectious diseases, including measles, polio, diphtheria, and influenza. These vaccines stimulate the immune system to recognize and fight harmful pathogens, reducing morbidity and mortality rates. Childhood vaccination programs are essential in preventing outbreaks and maintaining herd immunity. Regulatory bodies like the CDC and WHO establish immunization schedules to ensure early and effective protection. The pediatric vaccine market continues to grow due to increasing awareness and government initiatives.

List of the Key Players in the Pediatric Vaccines Market:

Pfizer Inc., Sanofi SA, Merck & Co., Takeda Pharmaceuticals, Indian Immunological limited, Bharat Biotech, Panacea Biotec, Sinovac Biotech, AstraZeneca, and Novartis AG.

Industry Development:

This approval expands Pfizer's pediatric vaccine portfolio, enhancing protection against invasive pneumococcal disease (IPD) and otitis media in children. PREVNAR 20 provides broader coverage against 20 pneumococcal serotypes, addressing a significant public health need. The vaccine is particularly beneficial for infants and young children, who are at higher risk of severe pneumococcal infections. This regulatory milestone strengthens Pfizer's position in the pediatric vaccine market and aligns with ongoing efforts to reduce pneumococcal disease burden worldwide.

Market Dynamics:

The increasing prevalence of chronic and infectious diseases is a key factor driving the growth of the global pediatric vaccine market. The rising incidence of infections has heightened awareness and concern among individuals, leading to a growing demand for pediatric vaccinations as a preventive measure to safeguard children's health.

The infection rate is particularly high among individuals already affected by infectious diseases. According to the World Health Organization (WHO), in 2024, an estimated 136,000 measles-related deaths occurred globally in 2022, primarily among unvaccinated or under-vaccinated children under the age of five. This alarming statistic underscores the critical need for vaccination programs to protect vulnerable populations.

Additionally, the National Foundation for Infectious Diseases highlights that influenza (flu) remains a serious illness, causing thousands of hospitalizations each year, particularly among children under five. On average, 20,000 children in this age group are hospitalized annually due to flu-related complications. These factors collectively reinforce the importance of pediatric vaccines and are expected to drive significant market growth.

For Direct Purchase: https://www.datamintelligence.com/buy-now-page?report=pediatric-vaccines-market?rk

Growth Forecast Projected:

The Global Pediatric Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Pediatric Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/pediatric-vaccines-market?rk

Segment Covered in the Pediatric Vaccines Market:

By Disease Type: Infectious Diseases, Allergies.

By Vaccine Type: Monovalent Vaccines, Multivalent Vaccines.

By Technology: Live attenuated Vaccines, Inactivated Vaccines, Sub-unit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Others.

Regional Analysis for Pediatric Vaccines Market:

The regional analysis of the Pediatric Vaccines Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pediatric-vaccines-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Pediatric Vaccines market?

➠ Who are the leading manufacturers in the global Pediatric Vaccines industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Pediatric Vaccines industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Pediatric Vaccines market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/pediatric-vaccines-market?rk

Influenza Vaccines Market: https://www.datamintelligence.com/research-report/influenza-vaccines-market?rk

Shingles Vaccines Market: https://www.datamintelligence.com/research-report/shingles-vaccines-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.